TUBB3 predicts prognosis in patients with metastatic prostate cancer under abiraterone therapy Feb. 20, 2020
APOBEC3B predicts good prognosis with gemcitabine plus platinum therapy in patients with mUC Feb. 20, 2020
KRT5 and KRT20 found to predict treatment response in patients with muscle-invasive bladder cancer Feb. 18, 2020